Neuromuscular Disease News

Black patients with ALS experienced a greater median survival than white patients in a large, single-center study, though researchers found no independent association between race and survival after adjusting for ALS prognostic factors.

Healio Neurology has complied a list of the posts neurologists and other health care professionals read most in 2020.

Treatment with vamorolone, an anti-inflammatory steroidal drug, improved motor outcomes in boys with Duchenne muscular dystrophy compared with corticosteroid-naive individuals, according to findings published in PLoS Medicine.

Patients with ALS who have an expansion in the C9orf72 gene displayed a different neuropsychological profile, with greater impairment in executive function and verbal memory, than patients with ALS who did not have the expansion.

AMX0035, an investigational neuroprotective therapy, reduced the risk for death by nearly half in patients with amyotrophic lateral sclerosis according to results of an overall survival analysis from the CENTAUR trial.

Although patients with degenerative cervical myelopathy are mainly treated with surgery, patients saw improvement in arm and neck pain when treated with riluzole, a drug typically used in patients with amyotrophic lateral sclerosis.

In this video from the Annual Meeting of the American Neurological Association, Conrad "Chris" Weihl, MD, PhD, discusses the plenary session he co-chaired on the genomics of personalized medicine.

Researchers found that about one in five patients who visited a neurologist had to travel outside their home region for care, and the median travel distance was approximately 68 miles round trip.

Women with Charcot-Marie Tooth disease experienced higher rates of placenta previa, abnormal non-vertex presentations and preterm deliveries compared with controls, according to findings from an Italian registry.

Coformulated, fixed-dose sodium phenylbutyrate–taurursodiol reduced the rate of functional decline compared with placebo in patients with amyotrophic lateral sclerosis, or ALS, according to findings from the CENTAUR study.